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Background. It is not entirely clear whether ischemia burden on stress single-photon
emission computed tomography (SPECT) effectively identifies patients who have a long-term
benefit from coronary revascularization.
Methods. The study population consisted of 719 patients with ischemia on stress SPECT.
Early coronary revascularization was defined as percutaneous coronary intervention or coro-
nary artery bypass grafting £90 days after SPECT. Patients who underwent late
revascularization (>90 days after SPECT) were excluded (n 5 164).
Results. Of the 538 patients (73% men, mean age 59.8 ± 11 years), 348 patients had low
ischemia burden (<3 ischemic segments) and 190 patients had moderate to high ischemia
burden (‡3 ischemic segments). A total of 76 patients underwent early revascularization.
During a median follow-up of 12 years (range 4-17), 283 patients died of whom 125 due to
cardiac causes. Early revascularization was beneficial on all-cause mortality (HR 0.46, 95% CI
0.30-0.46) and cardiac mortality (HR 0.54, 95% CI 0.29-0.99).
Conclusions. Patients with myocardial ischemia on stress SPECT who underwent early
revascularization had a lower all-cause mortality and cardiac mortality during long-term fol-
low-up as compared to patients who received pharmacological therapy alone. This difference in
long-term outcomes was mainly influenced by the survival benefit of early revascularization in
the patients with moderate to high ischemia burden. (J Nucl Cardiol 2016)
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Abbreviations
CABG Coronary artery bypass grafting
CAD Coronary artery disease
PCI Percutaneous coronary intervention
ECG Electrocardiography
MBq Megabecquerel
MI Myocardial infarction
MPI Myocardial perfusion imaging
SPECT Single-photon emission computed
tomography
99mTc Technetium-99m
INTRODUCTION
Advances in pharmacotherapy have substantially
improved the symptoms and long-term outcomes of
patients with stable coronary artery disease (CAD) over
the last decades. A subset of these patients may also
benefit from coronary revascularization. The survival
benefit of coronary revascularization is related to the
amount of myocardial ischemia. Stress single-photon
emission computed tomography (SPECT) myocardial
perfusion imaging (MPI) is a reliable tool to assess the
ischemia burden and may be used to identify coronary
revascularization candidates.1 Patients with CAD and
ischemia on stress SPECT have higher risk of all-cause
mortality and myocardial infarction (MI) compared to
patients without ischemia.2 Previous data showed that
coronary revascularization may be beneficial over med-
ical therapy in patients with moderate to severe
ischemia.3 Randomized trials showed that early revas-
cularization showed no improvement in all-cause
mortality or myocardial infarction (MI) compared to
optimal medical therapy.4,5 However, nuclear substudies
of these randomized trials are conflicting.6,7 Moreover,
long-term information after early coronary revascular-
ization in patients with ischemia on stress SPECT is
lacking. Therefore, the primary aim of this study was to
evaluate the impact of early coronary revascularization
on long-term outcomes in patients with myocardial
ischemia on stress SPECT. The second goal was
whether the ischemia burden on stress SPECT determi-
nes the prognostic benefit of revascularization.
METHODS
Study Design
A total of 2215 consecutive patients who underwent stress
SPECT between November 1990 and May 2002 (Figure 1)
were screened. Patients who had no ischemia (ischemia was
defined as the presence of a reversible or partially reversible
perfusion defect) on stress SPECT were excluded. Of this
study population, 75 patients were excluded because of
uninterpretable or missing SPECT data. The initial study
population consisted of 719 patients with ischemia. Follow-up
was complete in 702 (98%) patients. Early coronary revascu-
larization was defined as percutaneous coronary intervention
(PCI) or coronary artery bypass grafting (CABG) B90 days
after SPECT MPI. Patients who underwent late revasculariza-
tion (defined as[90 days after SPECTMPI) were also excluded
(n = 164). Thus, the data presented are based on a final study
population of 538 patients. Patients underwent exercise bicycle
(n = 220) or dobutamine (n = 318) stress SPECT. At the time
of this study, dobutamine was the preferred stressor in our
nuclear cardiology laboratory. The type of stress test was
selected based on the patient’s ability to exercise. During the
period in which the stress test was performed, both bare metal
stents (from the middle of 1993, n = 71) and drug-eluting stents
were implanted (from 2000, n = 5). Before the stress test, a
structured clinical interview and cardiac risk factors were
acquired. A blood pressure C140/90 mm Hg or treatment with
antihypertensive medication was considered as hypertension. A
fasting glucose level C7.8 mmol/L or the need for insulin or
oral hypoglycemic agents was considered as diabetes mellitus.
A total cholesterol C6.4 mmol/L or treatment with lipid-
lowering medication was considered as hypercholesterolemia.
Heart failure was defined according to the New York Heart
Association classification.8 All patients gave informed consent
before testing and consented participation in this study. The
local ethics committee approved the study protocol.
Stress Test Protocol
Symptom-limited, upright, bicycle ergometry with step-
wise increments of 20 W every minute was performed. Three
electrocardiographic leads were continuously monitored. Cuff
blood pressure measurements and 12-lead electrocardiograms
were recorded at rest and every minute during exercise and
recovery. In patients who were unable to perform exercise tests,
dobutamine stress testing was performed as previously
reported.9 Dobutamine was administered intravenously, start-
ing at a dose of 5 lg/kg/minutes for 3 minutes, then 10 lg/kg/
minutes for 3 minutes, increasing by 10 lg/kg/minutes every 3
minutes up to a maximum dose of 40 lg/kg/minutes. If the test
endpoint was not reached at a dobutamine dose of 40 lg/kg/
minutes, atropine (up to 2 mg) was given intravenously. Blood
pressure, heart rate, and electrocardiography were monitored
continuously. Test endpoints were achievement of target heart
rate (85% of maximum age and gender-predicted heart rate),
horizontal or downsloping ST-segment depression[2 mm at an
interval of 80 ms after the J point, ST-segment elevation[1 mm
in patients who had no previous myocardial infarction, severe
angina, systolic blood pressure decrease[40 mm Hg, blood
pressure[240/120 mm Hg, or significant cardiac arrhythmias.
SPECT Imaging
An intravenous dose of 370 MBq of 99mTc-tetrofosmin
(n = 234) or 99mTc-sestamibi (n = 304) was injected
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approximately 1 minute before the cessation of exercise. In rest
studies, 370 MBq of tetrofosmin or sestamibi was administered
at least 24 hours after the stress test. Myocardial images were
acquired with a triple-head gamma-camera system (Picker
Prism 3000 XP, Cleveland, Ohio, USA). Data were stored in a
64 9 64 matrix. The image data were reconstructed by filtered
backprojection using a Butterworth filter (cutoff frequency,
0.17 cycles per pixel); 6-mm-thick (1 pixel) transaxial slices
were obtained. The interpretation of the SPECT was semi-
quantitatively performed by visual analysis and aided by
circumferential profiles analysis. Stress and rest tomographic
views were reviewed side by side by an experienced observer
who was blind to the patients’ clinical information. A
reversible perfusion defect was defined as a perfusion defect
on the exercise images that partially or completely resolved at
rest in at least two contiguous segments. A fixed perfusion
defect was defined as a perfusion defect on exercise images,
which persists on rest images. To assess the severity of
perfusion abnormalities, the left ventricular myocardium was
divided into 6 segments: anterior, inferior, septal anterior,
septal posterior, posterolateral, and apical. Each of the 6 major
left ventricular segments was scored using a 4-point scoring
method (0 = normal, 1 = slightly reduced, 2 = moderately
reduced, and 3 = severely reduced or absent uptake). The
extent of myocardial ischemia on stress SPECT was defined by
the number of segments with reversible or partially reversible
perfusion defects. Low ischemia burden was defined as the
presence of reversible perfusion abnormalities in\3 segments,
whereas moderate to high ischemia burden was defined as C3
ischemic segments on SPECT.7
Follow-up
Outcome data were obtained by a questionnaire, evalu-
ation of hospital records, contacting the patient’s general
practitioner, and/or review of civil registries. The online
municipal civil registry was used to determine the patient’s
present survival status. The date of response was used to
calculate follow-up time. The endpoints considered were all-
cause mortality and cardiac mortality. Causes of death were
obtained from the Central Bureau of Statistics Netherlands
(www.cbs.nl). A death caused by acute MI, significant
arrhythmias, refractory heart failure, or sudden death without
other explanation was defined as cardiac mortality.
Statistical Analysis
Statistical analysis was performed using SPSS version 22
(IBM, Armonk, New York). Continuous data are expressed as
mean ± SD and percentages are rounded. Continuous variables
were compared with Student’s t test for unpaired samples.
Differences between proportions were compared with the chi-
squared test. Logistic regression analysis was used to develop a
propensity score to summarize predictors of the decision of
referral to revascularization. Variables known to influence the
decision to referral for revascularization were considered for
entry in the logistic regression. This approach was followed by
incorporating the propensity score as a covariate in the
multivariable regression model. Kaplan-Meier survival curves
were performed and were compared using the log-rank test.
The impact of early coronary revascularization on survival was
investigated using univariable and multivariable Cox’s pro-
portional hazard regression models. The multivariable model
was performed using known prognostic factors, including
cardiac risk factors, stress SPECT results, and the propensity
score. Linearity of the relationship between covariates and
survival in the Cox regression model was assessed using the
martingale residuals. Plots of the residuals against the pre-
dicted values showed linearity and homoscedasticity. The
assumption of the proportional hazards was evaluated by
Total number of paents who
underwent stress 99mTc-SPECT
(N = 2215)
Inial paent populaon with 
ischemia
(N = 719)
Paents excluded:
- No ischemia (N = 1421)
- Uninterpretable or missing data (N = 75)
Paents excluded:
- Lost to follow-up (N = 17)
- Late coronary revascularizaon (N = 164)
Final paent populaon
(N = 538)
Early coronary revascularizaon
(N = 76)
No early coronary revascularizaon
(N = 462)
Figure 1. CONSORT diagram of the study population selection.
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performing the log-minus-log survival plot; the assumption
was met. To investigate collinearity, interaction terms were
used; no interactions were observed. The risk of a variable was
expressed as a hazard ratio (HR) with a corresponding 95%
confidence interval (95% CI). P\ .05 was considered statis-
tically significant.
RESULTS
Patient Characteristics
The 538 patients with myocardial ischemia on stress
SPECT are characterized in Table 1. Mean age and
mean body mass index (BMI) were 59.8 ± 11 years and
26.8 ± 4.4, respectively. A total of 395 (73%) patients
were men. Regarding stress testing, 220 patients (41%)
underwent exercise bicycle stress and 318 patients
(59%) underwent dobutamine stress. Typical angina
occurred in 150 patients (28%), whereas 176 patients
(33%) exhibited ST-segment changes.
All patients had myocardial ischemia (defined as
reversible or partially reversible perfusion defect) on
stress SPECT. Fixed defects were observed in 81 (15%)
patients. Both fixed and reversible defects were present
in 344 (64%) patients. A total of 348 patients (65%) had
low ischemia burden and 190 patients (35%) had
moderate to high ischemia burden. A total of 76 (14%)
patients underwent early revascularization (B90 days
after the stress SPECT); PCI was performed in 53 (70%)
patients, and CABG was performed in 27 (36%)
patients. A total of 4 patients (5%) underwent both
PCI and CABG. The remaining 462 patients with
myocardial ischemia on stress SPECT were treated only
with pharmacologic therapy. Among the 76 patients who
underwent early revascularization, mean number of
abnormal segments was 2.5 ± 1.2 compared to
2.1 ± 1.1 in patients without early revascularization
(p = 0.005). Patient groups were comparable according
to age, BMI, smoking, hypertension, hypercholes-
terolemia, heart failure, diabetes mellitus, and previous
MI (Table 1). Comparison of the patient groups shows
that the patients who underwent early coronary revas-
cularization were more frequent men, had more prior
revascularization, and had more moderate to high
ischemia burden. These factors may have contributed
to referring for early coronary revascularization.
Long-Term Outcomes
During a median follow-up of 12 years (range 4-
17), a total of 283 (53%) patients died (all-cause
mortality) of whom 125 (44%) were due to cardiac
causes. Kaplan-Meier survival curves are demonstrated
in Figures 2, 3, 4, 5, and 6. Survival curves showed that
patients with myocardial ischemia on stress SPECT who
underwent early revascularization had a lower risk for
all-cause mortality (event-free survival: 88 vs 72% at 5
years, 79 vs 55% at 10 years, 65 vs 44% at 15 years;
overall P\ .001, Figure 2) and cardiac mortality
(event-free survival: 93 vs 82% at 5 years, 88 vs 76%
at 10 years, 83 vs 72% at 15 years; overall P = .03,
Figure 3). As Figures 4 and 5 shows, this lower risk was
not influenced by the 348 patients with low ischemia
burden (all-cause mortality, P = .10, Figure 4, and
cardiac mortality, P = .32, Figure 5). In contrast, in
the 190 patients with moderate to high ischemia burden,
early revascularization was associated with better long-
term outcomes compared to patients without early
revascularization (all-cause mortality, P\ .001, Fig-
ure 4; cardiac mortality, P = .03, Figure 5). Figure 6
shows Kaplan-Meier curves for the endpoint of cardiac
mortality in patients who underwent early revascular-
ization stratified to involvement of the left anterior
descending artery (LAD). Of the 76 patients who
underwent early revascularization, involvement of the
LAD was associated with worse long-term outcomes
compared to patients without LAD involvement.
Patients who were able to perform exercise bicycle
testing had a better prognosis as compared with the
patients who underwent dobutamine stress testing. In
patients who underwent early revascularization, all-
cause mortality was significantly higher in the dobu-
tamine group than in the exercise group (Figure 7).
Univariable and Multivariable Predictors of
Outcome
Logistic regression identified prior revasculariza-
tion, male gender, and number of abnormal segments on
SPECT as the best predictors of referral to revascular-
ization (P\ .05). Univariable and multivariable
predictors of long-term outcome are presented in
Tables 2 and 3, respectively. Univariable predictors of
all-cause mortality were age, male gender, hypertension,
diabetes mellitus, hypercholesterolemia, heart failure,
prior MI, and number of abnormal segments on SPECT
(Table 2). Univariable predictors of cardiac mortality
were age, hypertension, diabetes mellitus, heart failure,
previous MI, and number of abnormal segments on
SPECT (Table 2). The univariable analysis also demon-
strated that early revascularization was inversely related
to both endpoints of interest.
The results of the multivariable analysis are shown
in Table 3. Age, male gender, hypertension, diabetes
mellitus, hypercholesterolemia, smoking, heart failure,
previous revascularization, propensity score, and a
number of abnormal segments on SPECT were associ-
ated with all-cause mortality (Table 3). Multivariable
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predictors of cardiac mortality were age, male gender,
diabetes mellitus, and heart failure (Table 3). The
multivariable Cox regression model revealed that early
revascularization had a beneficial effect on both all-
cause mortality (HR 0.46, 95% CI 0.30-0.69) and
cardiac mortality (HR 0.54, 95% CI 0.29-0.99).
DISCUSSION
The present study evaluated the impact of early
revascularization (B90 days after stress SPECT) on
long-term outcome in patients with myocardial ischemia
on stress SPECT. Of the 538 patients, 30% of patients
had previous revascularization and 41% had previous
MI. During a median follow-up of 12 years, a total of
283 (53%) patients died (all-cause mortality) of whom
125 (44%) were due to cardiac causes. Kaplan-Meier
survival curves showed that early revascularization
(either PCI or CABG) after an ischemic stress SPECT
was beneficial on both all-cause mortality and cardiac
mortality. In patients with low ischemia burden on stress
SPECT (defined as\3 ischemic segments), early revas-
cularization was not associated with better long-term
outcomes, whereas in patients with moderate to severe
ischemia burden (defined as C3 ischemic segments),
early revascularization was associated with better long-
Table 1. Clinical characteristics of 538 patients with reversible perfusion defects
Value (%)
All
(N 5 538)
Early revascularization
(N 5 76)
No early revascularization
(N 5 462)
P
value
Age 59.8 ± 11 59.8 ± 9 59.8 ± 11 .96
Male gender 395 (73) 64 (84) 331 (72) .02
BMI 26.8 ± 4.4 26.9 ± 3.4 26.9 ± 4.5 .99
Cardiac risk factors
Smoking 158 (29) 23 (30) 135 (29) .85
Hypertension 215 (40) 28 (37) 187 (40) .55
Hypercholesterolemia 188 (35) 31 (41) 157 (34) .25
Heart failure 82 (15) 9 (12) 73 (16) .37
Diabetes mellitus 84 (16) 11 (14) 73 (16) .77
Previous
revascularization
161 (30) 34 (45) 127 (27) .002
Previous MI 223 (41) 37 (49) 186 (40) .17
Medications
ACE-inhibitors 156 (29) 22 (38) 134 (29) .99
Beta blockers 243 (45) 53 (70) 191 (41) \.001
Calcium-channel
blockers
209 (39) 43 (57) 166 (36) \.001
Diuretics 116 (22) 10 (13) 106 (23) .06
Nitrates 188 (35) 32 (42) 156 (34) .16
Stress type
Exercise bicycle 220 (41) 42 (55) 178 (39) .01
Dobutamine 318 (59) 34 (45) 284 (61) .01
SPECT parameters
Number of abnormal
segments
2.2 ± 1.5 2.5 ± 1.2 2.1 ± 1.1 .005
Low ischemia burden* 348 (65) 38 (50) 310 (67) .004
Moderate to high
ischemia burden*
190 (35) 38 (50) 152 (33) .004
Values are expressed as means ± SD or numbers (%)
BMI, body mass index; MI, myocardial infarction; ACE, angiotensin-converting-enzyme; SPECT, single-photon emission com-
puted tomography
* Low ischemia burden = 1 or 2 abnormal segments. Moderate to high ischemia burden = C3 abnormal segments
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term outcomes. The multivariable model demonstrated
that early revascularization was associated with a 54%
reduction in all-cause mortality and a 46% reduction in
cardiac mortality. Also, in patients who underwent early
revascularization without involvement of the LAD,
cardiac mortality was lower compared to patients who
were revascularized with involvement of the LAD.
Regarding the type of stress test, patients with early
revascularization who performed a dobutamine stress
test had higher all-cause mortality compared to patients
who performed exercise bicycle stress testing. This
finding is in accordance with a previous report from our
center.10 The inability to perform exercise testing is a
negative prognostic marker in patients with CAD.
Figure 2. Kaplan-Meier curves for all-cause mortality accord-
ing to strata of early coronary revascularization.
Figure 3. Kaplan-Meier curves for cardiac mortality accord-
ing to strata of early coronary revascularization.
Figure 4. Kaplan-Meier curves for all-cause mortality accord-
ing to strata of the extent of ischemia (low ischemia burden vs
moderate to high ischemia burden) and early coronary
revascularization (revasc vs no revasc).
Figure 5. Kaplan-Meier curves for cardiac mortality accord-
ing to strata of the extent of ischemia (low ischemia burden vs
moderate to high ischemia burden) and early coronary
revascularization (revasc vs no revasc).
Figure 6. Kaplan-Meier survival curves for the endpoint of
cardiac mortality in patients who underwent early revascular-
ization stratified to involvement of the left anterior descending
artery (LAD) (LAD vs no LAD involved).
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In recent years, there has been a considerable
interest concerning treatment strategies in patients with
stable CAD resulting in a wealth of published literature.
Both revascularization (PCI and/or CABG) and optimal
medical therapy are treatment options in these patients.
SPECT MPI plays a central role in this regard. To date,
information on long-term outcomes after revasculariza-
tion in relation to the ischemia burden on stress SPECT
is relatively scarce. Previous studies have examined the
short-term to medium-term outcomes after revascular-
ization in patients with ischemia on SPECT.
Hachamovitch et al3 studied[10.000 patients without
previous MI and without previous revascularization who
underwent stress SPECT. The study population was
divided in patients who were treated medically and
patients who underwent early revascularization and was
followed during a mean follow-up of 1.9 years. In
patients with moderate to severe ischemia ([10%
myocardial ischemia), revascularization was associated
with improved survival in comparison to medical
therapy. Sorajja et al11 evaluated 826 asymptomatic
diabetic patients without known CAD who underwent
exercise, adenosine, or dobutamine stress SPECT.
SPECT images were classified as low, intermediate,
and high risk. A total of 261 patients (32%) had a high-
risk SPECT (defined as a summed stress score B47,
based on: the lower the score the higher the radioisotope
uptake). During a mean follow-up of 5.7 ± 3.3 years,
CABG was associated with better survival in patients
with moderate to severe ischemia. The current study
differs from these previous studies for several reasons.
First, the current study evaluated a high-risk patient
group (30% had previous revascularization and 41% had
previous MI vs 0% in the studies of Hachamovitch et al
and Sorajja et al). Second, this study showed higher
event rates. This may be explained by the high preva-
lence of cardiac history indicating a higher risk status in
contrast to these previous studies. Also, during the
current long-term follow-up natural progression of CAD
may have occurred. Third, the mean follow-up duration
in these previous studies was 1.9 and 5.7 years. In the
present long-term follow-up study, median follow-up
duration was 12 years. To our knowledge, this is the first
study that has examined the impact of early revascular-
ization in relation the amount of ischemia in patients
with stable CAD for long-term ([10 years) outcome.
Figure 7. Kaplan-Meier survival curves for the endpoint of
all-cause mortality in patients who underwent early revascu-
larization stratified to stress type (exercise test vs dobutamine
stress test).
Table 2. Univariable predictors of all-cause mortality and cardiac mortality
Variable
All-cause mortality Cardiac mortality
HR 95% CI HR 95% CI
Age* 1.06 1.04–1.07 1.06 1.04–1.07
Male gender 1.34 1.09–1.77 1.29 0.85–1.97
Hypertension 1.57 1.24–1.98 1.60 1.12–1.27
Diabetes mellitus 2.47 1.87–3.27 3.14 2.13–4.62
Hypercholesterolemia 0.67 0.52–0.87 0.70 0.48–1.03
Smoking 1.04 0.80–1.34 0.96 0.65–1.42
Heart failure 2.34 1.79–3.18 2.99 2.01–4.45
Previous revascularization 1.08 0.84–1.38 1.19 0.82–1.73
Previous MI 1.46 1.15–1.84 1.69 1.19–2.41
# abnormal segments on SPECT 1.13 1.02–1.24 1.20 1.04–1.39
Early revascularization 0.46 0.30–0.69 0.52 0.29–0.95
* Per unit increment
#, number; MI, myocardial infarction; SPECT, single-photon emission computed tomography
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This study extends the conclusions drawn from these
previous studies in that early revascularization in
patients with moderate to high ischemia burden is
beneficial during long-term outcome. The current find-
ings are also in line with previous data which indicates
that a certain amount of ischemia has to be present for
revascularization to be beneficial.12
In a nuclear substudy of the COURAGE trial,6 a
total of 314 patients were enrolled who underwent either
exercise or vasodilator stress 99mTc-sestamibi SPECT.
Moderate to severe ischemia on SPECT was defined as
C10% myocardium. The authors found that the magni-
tude of residual ischemia was proportional to the risk of
all-cause mortality. However, as the authors noted, these
findings are based on underpowered data due to the
small proportion of enrolled patients.6 More recently, a
second nuclear substudy of the COURAGE trial was
performed.7 Of the 1381 patients who underwent
SPECT, 699 patients were treated medically and 682
patients received medical treatment and PCI. Patients
were followed for a median follow-up of 4.6 years. The
extent of ischemia was not associated with adverse
events; the event rates in both mild ischemia and
moderate-severe ischemia were similar according to
treatment options (medical treatment or medical treat-
ment combined with PCI). In the current long-term
follow-up study, early revascularization was associated
with lower all-cause mortality and cardiac mortality.
There are several differences between the current
study and the COURAGE nuclear substudies.6,7 First,
the present study demonstrates that survival was signif-
icantly different between patients with revascularization
and those without during a median follow-up duration of
12 years. The maximum follow-up duration in the
previous trials was approximately 5 years. Second, while
the previous mentioned trials enrolled mainly low to
intermediate risk patients, the current study describes a
high-risk group of patients who were unable to perform
an exercise test. Third, 41% of the 538 patients (vs 38%)
had a previous myocardial infarction and 82 (15%)
patients (vs 4.7%) had known heart failure compared to
the COURAGE trial. Finally, in contrast to the previous
trials which had a randomized design, the current study
is of retrospective observational design with inherent
limitations. However, the current study describes ‘physi-
cian—selected’ patients which are commonly
encountered in with daily practice; all of these factors
may have influenced the beneficial effect of early
coronary revascularization in this high-risk group of
patients.
NEW KNOWLEDGE GAINED
In patients with myocardial ischemia on stress
SPECT, early coronary revascularization is associated
with lower all-cause mortality and cardiac mortality
during long-term follow-up ([10 years) as compared to
patients who received pharmacological therapy only.
LIMITATIONS
This study has several limitations. First, the deci-
sion to perform coronary revascularization was made by
the treating physician, this could have influenced the
Table 3. Multivariable predictors of all-cause mortality and cardiac mortality
Variable
All-cause mortality Cardiac mortality
HR 95% CI HR 95% CI
Age* 1.07 1.05–1.08 1.06 1.04–1.09
Male gender 1.95 1.40–2.71 1.80 1.10–2.93
Hypertension 1.31 1.02–1.68 1.22 0.84–1.77
Diabetes mellitus 2.42 1.78–3.28 2.96 1.94–4.54
Hypercholesterolemia 0.76 0.58–0.99 0.79 0.53–1.18
Smoking 1.52 1.15–2.00 1.41 0.93–2.14
Heart failure 1.35 1.97–1.88 1.60 1.00–2.56
Previous revascularization 1.45 1.04–2.03 1.56 0.95–2.57
Previous MI 1.08 0.82–1.41 1.20 0.81–1.80
Propensity score 0.04 0.01–0.50 0.05 0.00–1.83
# abnormal segments on SPECT 1.19 1.03–1.38 1.23 0.99–1.52
Early revascularization 0.46 0.30–0.69 0.54 0.29–0.99
* Per unit increment
#, number; MI, myocardial infarction; SPECT, single-photon emission computed tomography
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results. Although the current study was of observational
design—in contrast to the COURAGE nuclear substud-
ies6,7—we tried to avoid bias for referral to
revascularization using a propensity score. However,
limitations inherent of the observational design, like
missing covariates cannot be ignored. Because this is a
nonrandomized observational study, the results should be
interpreted with caution and should be viewed in con-
junction with the results from randomized trials. Second,
at time of data collection, medications were underused in
view of the current treatment guidelines, maybe because
the beneficial effect of thesemedications was not yet fully
understood.13 Third, the use of a 6-segment myocardial
model is less accurate compared to the standard 17-
segment myocardial model. However, this strategy has
been previously described in literature.7 This could have
influenced the outcome. Fourth, the patient population
was relatively small. Thismay have influenced the results.
Finally, the prognostic value of gated SPECT was not
examined, due to the fact that at the time of data
collection-gated SPECT was not routinely performed in
our center. As a result left ventricular ejection fraction
(LVEF)was not available. Information about LVEF could
have improved the analysis of the current study.
CONCLUSION
Patients with myocardial ischemia on stress SPECT
who underwent early revascularization had a lower all-
cause mortality and cardiac mortality during long-term
follow-up as compared to patients who received phar-
macological therapy alone. This difference in long-term
outcomes was mainly influenced by the survival benefit
of early revascularization in the patients with a moderate
to high ischemia burden. In patients with low ischemia
burden, early coronary revascularization had no benefi-
cial impact on long-term outcomes as compared to a
treatment strategy based on pharmacological therapy
alone.
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